SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-13-005729
Filing Date
2013-10-04
Accepted
2013-10-04 09:24:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 d1416739_13g.htm SC 13G 202260
  Complete submission text file 0000919574-13-005729.txt   203801
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Subject) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50211 | Film No.: 131135630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 237 PARK AVENUE, 9TH FLOOR NEW YORK NY 10017
Business Address 237 PARK AVENUE, 9TH FLOOR NEW YORK NY 10017 212-808-2463
Broadfin Capital, LLC (Filed by) CIK: 0001511901 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G